Randomized trials in patients with advanced non-small-cell lung cancer (NSCLC) have demonstrated that the combination of vinorelbine (Navelbine) and cisplatin
Jennifer Garst, MD
Advertisement
Articles by Jennifer Garst, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Melanoma Vaccine Receives FDA Fast Track Designation
2
TERN-701 Earns FDA Breakthrough Therapy Designation in Ph+ CML
3
Duvelisib Shows Significant Activity in R/R Peripheral T-Cell Lymphoma
4
Second-Line Strategy After IO and TKI in Advanced Renal Cell Carcinoma
5